Latest Posters
Poster
A Breakthrough in mRNA Therapy Development
Obtaining enough synthetic mRNA for clinical use has long been a hurdle in treating conditions like cancer and infectious diseases.. Current mRNA production methods involve complex purification steps and chemicals, limiting large-scale manufacturing.
Poster
Accelerating Antibody Discovery Using BLI Biosensor Technology
Biolayer Interferometry (BLI) technology has greatly advanced the process of antibody discovery, and the latest platforms offer reliable, high precision analysis which researchers can rely on.
Poster
AAV Purification Techniques To Advance Gene Therapy
This poster highlights several methods by which the downstream purification of viral vectors can be improved using chromatography methods to analyse and purify multiple AAV serotypes.
Poster
Upgrade Your Monoclonal Antibody Purification Workflow
Recent advancements in affinity technology now support more robust and efficient Protein A chromatography. Hence, the latest Protein A solutions can enhance productivity, yield and accelerate products to market.
Poster
Spatially Profile Human Immune Cells Within FFPE Tissue Samples
Despite the valuable transcriptomic information provided by probe-based spatial assays, detecting immune cell infiltration can pose challenges
Poster
Simultaneous Measurement of Genetics and Epigenetics Enables New Biological Insight
There is more to DNA than A, C, G and T, epigenetics plays a causal role in cell fate, aging and disease development. Genetic and methylation data together on the same read allow us to get a more complete picture of genome biology. Constrained to measuring four states of information, existing NGS- based technologies sacrifice genetic for methylation calling.
Poster
Refining Liquid Biopsy: Generating More Information From Cell Free DNA
Liquid biopsy for profiling of cell free DNA (cfDNA) in blood holds huge promise to transform how we experience and manage cancer by early detection and identification of residual disease and subtype. However, a standard blood draw yields an average of only 10 ng of cfDNA, of which DNA derived from the tumor is a small minority.
Poster
Accelerating Antibody Drug Development With Subdomain-Specific Affinity Chromatography
Affinity purification platforms such as Protein A or L are well-established in the manufacturing process of therapeutic monoclonal antibodies. However, with the development of engineered modalities such as bi-specific antibodies, fragments and Fc-fusion proteins, challenges in the downstream process of these molecules arise.
Poster
Kinetic Analysis: Spotting the Weakest Binders
Designing and performing assays that accurately measure small molecule binding kinetics is an important part of the drug discovery process. It allows researchers to predict the efficacy of potential novel therapeutics and make quick decisions about weak binders.
Poster
The Latest Analytical Techniques for PFAS Monitoring
This poster compilation outlines the latest LC-MS/MS and QTOF MS methods for accurate environmental monitoring.
Advertisement